InvestorsHub Logo
Followers 18
Posts 6665
Boards Moderated 0
Alias Born 03/06/2010

Re: no2koolaid post# 372543

Saturday, 08/20/2022 6:44:58 PM

Saturday, August 20, 2022 6:44:58 PM

Post# of 401949
New approvals haven’t been launched. Uncertainty about launching Doxy. No timetable about launching Sabril or even Adderall in Israel. Adderall ER with largest market does squat with Lannett. There’s a significant amount of uncertainty, which is what investors hate. We don’t know what is near term, midterm or long term with this company. Very little is divulged and what is rarely comes to pass.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News